T HE ADRENAL cortex is a major source of steroid hormones, which are synthesized from cholesterol through the sequential actions of a series of cytochrome P450 enzymes (1) . The adrenal cortex of adult mice is divided into morphologically and functionally distinct layers or zones (2) . Mineralocorticoids are synthesized in the outermost layer, the zona glomerulosa (zg), whereas glucocorticoids are produced in the zona fasiculata (zf). Murine adrenal cortex also contains a so-called X-zone, which develops after birth adjacent to the medulla and disappears at puberty in males and after the first pregnancy in females (2) . In addition to this zonal organization, the adrenal cortex is arranged in radial cords of clonally related cells that extend from the zg to the zf (3) . The adult adrenal cortex undergoes continual renewal; stem cells near the junction of the zg and zf give rise to daughter cells, which are displaced centripetally, where they undergo apoptosis (3, 4) .
Certain inbred strains of mice develop adrenocortical tumors in response to gonadectomy (5) (6) (7) (8) (9) (10) . This process is strain dependent; adrenocortical adenomas form in DBA/2J and C3H mice, adrenocortical carcinomas develop in CE mice, whereas no adrenal tumors develop in C57BL/6J mice (5) (6) (7) (8) (9) (10) . When DBA/2J mice are gonadectomized, spindleshaped cells, known as A cells, proliferate in the subcapsular region of the adrenal cortex (5) (6) (7) . The function of these cells, which have limited steroidogenic capacity (9, 11, 12) , is unknown. Foci of sex steroid producing cells, termed B cells, appear later within patches of A cells (13) . This process is thought to represent metaplasia of competent cells in the adrenal cortex, which under the influence of unopposed pituitary gonadotropins transform into tissue resembling gonadal stroma (2, 10) . Hypophysectomy, parabiosis, and adrenal transplantation experiments have confirmed that the adrenal glands of DBA/2J, C3H, CE, and other susceptible strains exhibit an inherent predisposition to tumor formation in response to gonadotropin stimulation (6 -15) . However, the molecular mechanisms underlying this process have not been elucidated.
Two members of the GATA transcription factor family, Abbreviations: E12.5, Embryonic d 12.5; LHR, LH receptor; P450c17, P450 17␣-hydroxylase/C17-C20 lyase; P450scc, cytochrome P450 side-chain cleavage enzyme; RNase, ribonuclease; SF-1, steroidogenic factor-1; StAR, steroidogenic acute regulatory protein; SV40, simian virus 40; zf, zona fasiculata; zg, zona glomerulosa.
GATA-4 and GATA-6, have been implicated in the regulation of gene expression and differentiation in steroidogenic cell types, including Sertoli, Leydig, granulosa, and thecainterstitial cells (16 -22) . High level GATA-4 expression accompanies periods of active cell proliferation in Sertoli and granulosa cells (16 -18) , and gonadotropin stimulation of immature ovaries results in increased levels of GATA-4 mRNA (16) . In mice and humans, GATA-4 is expressed transiently in adrenocortical cells during fetal development, whereas GATA-6 is expressed in both fetal and adult adrenal cortex (23) . These differing expression profiles suggest that GATA-4 and GATA-6 have distinct roles in adrenocortical cell differentiation and function. Recent studies have shown that increased expression of GATA-4 accompanies adrenocortical tumorigenesis in humans and in gonadectomized inhibin-␣ promoter simian virus 40 (SV40) T antigen transgenic mice (24, 25) . In the adrenocortical tumors that develop in these transgenic mice, there is a concomitant increase in the expression of functional LH receptors (LHR), and the elevation in serum LH that accompanies gonadectomy is a prerequisite for tumor formation (26) .
Here we show that GATA-4, a transcription factor normally expressed in somatic/interstitial cells of the mouse ovary and testes, but not in adult adrenal, defines a population of cells that proliferate in the adrenal cortex of DBA/2J mice following gonadectomy. In addition to GATA-4, some of these neoplastic adrenocortical cells express transcripts for LHR and P450 17␣-hydroxylase/C17-C20 lyase (P450c17), an enzyme essential for the production of sex steroids, suggesting that these cells can respond directly to gonadotropin signals and synthesize sex steroids. These findings implicate GATA-4 and LHR in the process of gonadotropin-induced metaplasia in DBA/2J mice.
Materials and Methods

Experimental animals and treatments
All animal work was carried out in accordance with NIH Guidelines for the Care and Use of Laboratory Animals. Weanling DBA/2J or C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME), and weanling FVB/N mice were obtained from the Department of Pediatrics, CHRC Genetically Altered Mouse Core. The mice were specific pathogen free and were housed five per cage in controlled conditions of light (12 h of light, 12 h of darkness) and temperature (21 C). They were fed commercial mouse chow (Ralston Purina, St. Louis, MO) and tap water ad libitum. Mice were gonadectomized at 3-4 wk of age (27) . Avertin anesthesia was used during surgical procedures, and buprenorphine was used for postoperative analgesia (27) . At specified times the mice were killed by CO 2 inhalation. Blood samples were obtained at the time of death. At autopsy, adrenal glands were dissected, and adnexal regions were examined for evidence of ovarian regeneration (28) . Tissues were frozen in OCT cryopreservation media (TissueTek, Miles, Inc., Elkhart, IN), and then sectioned (10 m). Cryosections were fixed in 4% paraformaldehyde in PBS before in situ hybridization or immunohistochemistry. Alternatively, harvested tissue was fixed overnight in 4% paraformaldehyde in PBS, embedded in paraffin, and then sectioned (4 m) for immunohistochemistry or in situ hybridization. In some instances, harvested adrenal tissue was used to isolate total RNA (TRIzol reagent, Invitrogen, Carlsbad, CA).
Hormone measurements
Serum LH concentrations were measured using an immunofluorometric assay (Wallac Oy, Turku, Finland), as described previously (29) .
Immunohistochemistry
Paraffin-embedded, paraformaldehyde-fixed tissue sections were deparaffinized, hydrated, and treated with 10 mm citric acid, pH 6, in a microwave oven for 10 -30 min to facilitate antigen capture. Endogenous peroxidase was quenched with a methanol solution containing 0.5% H 2 O 2 . After incubation with blocking buffer (1.5% normal serum and 0.1% Tween-20 in PBS), sections were stained with the following primary antibodies: 1) polyclonal goat antimouse GATA-4 IgG (sc-1237, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), or 2) rabbit antimouse GATA-6 IgG (sc-9055, Santa Cruz Biotechnology, Inc.). The sections were exposed to the antibody at dilutions of 1:200 (GATA-4) or 1:500 (GATA-6) for 1 h at 37 C. The avidin-biotin immunoperoxidase system (Vectastain Elite ABC Kit, Vector Laboratories, Inc., Burlingame, CA) and diaminobenzidine (Sigma-Aldrich Corp., St. Louis, MO) were used to visualize the bound antibody; slides were then counterstained with 100% hematoxylin.
Preparation of riboprobe templates for cytochrome P450 side-chain cleavage enzyme (P450scc) and P450c17
Partial-length cDNAs for mouse P450scc and P450c17 were generated via RT-PCR of mRNA isolated from the Leydig cell tumor line, mLTC-1 (30). Previously described primers (31) were used to generate a 536-bp PCR product spanning nucleotides 110 -455 of mouse P450scc. A forward primer of 5Ј-CCAGATGGTGACTCTAGGCCTCTTGTC and a reverse primer of 5Ј-GGTCTATGGTAGTCAGTATGC were used to generate a 306-bp PCR product spanning nucleotides 331-631of mouse P450c17 (32) . PCR reaction mixtures, which included Taq polymerase, were processed for 30 cycles, each consisting of 94 C for 1 min, 55 C for 1 min, and 72 C for 3 min. The resultant PCR products were ligated into the T-A cloning site of pCRII (Invitrogen, Carlsbad, CA).
Ribonuclease (RNase) protection assays
These assays were performed with a commercially available kit (Ambion, Austin, TX) and 5 g total RNA.
32 P-Labeled antisense riboprobes were prepared by in vitro transcription in the presence of [ 32 P]CTP (800 Ci/mmol; ICN Biomedicals, Irvine, CA) using the following linearized plasmid templates and RNA polymerases: 1) GATA-4, NotI-digested pBluescript SK G14A, T7 polymerase (33); 2) LHR, BglII-digested pGEM plasmid, T7 polymerase (34); 3) P450c17, EcoRV-digested pCRII plasmid described above, Sp6 polymerase; and 4) GATA-6, PstI-digested pCRII plasmid, Sp6 polymerase (33) . Antisense ␤-actin probe was prepared from template provided by the manufacturer. The sizes of the full-length and protected RNA probes (in nucleotides) were as follows: GATA-4, 491 and 430 bp; P450c17, 324 and 306 bp; GATA-6, 600 and 140 bp; ␤-actin, 300 and 250 bp; LHR, 450 bp; and multiple protected fragments of varying sizes, due to alternative splicing of this transcript (35, 36 ) (see Fig. 5 ). Protected fragments were separated by PAGE and quantified using phosphorimage analysis, normalizing to the expression of ␤-actin.
In situ hybridization
Frozen or paraffin-embedded tissue sections were subjected to in situ hybridization as previously described (33) . Sections were incubated in a final volume of 80 l with 10 6 cpm 33 P-labeled antisense riboprobe prepared using [ 33 P]UTP (3000 Ci/mmol; ICN Biomedicals) and the following linearized plasmid templates and RNA polymerases: 1) GATA-4, BamHI-digested pBluescript SK G14A, T7 polymerase (33); 2) GATA-6, EcoRV-digested pCRII plasmid, Sp6 polymerase (33); 3) 11␤-hydroxylase, EcoRI-digested pBluescript plasmid, T3 polymerase (37); 4) P450 aldosterone synthase, EcoRI-digested pBluescript plasmid, T3 polymerase (37); 5) P450scc, HindIII-digested pCRII plasmid described above, T7 polymerase; 6) inhibin-␣, EcoRI-digested pGEM-4Z plasmid, T7 polymerase (38); 7) steroidogenic acute regulatory protein (StAR), SalI-digested pSport plasmid, SP6 polymerase (39); 8) P450c17, EcoRVdigested pCRII plasmid described above, Sp6 polymerase; 9) LHR, BglIIdigested pGEM plasmid, T7 polymerase (34); and 10) steroidogenic factor-1 (SF-1), HindIII-digested plasmid, T7 polymerase (40) .
Results
Morphological changes in the adrenal glands of gonadectomized DBA/2J mice
DBA/2J mice that undergo prepubertal gonadectomy develop nodular adenomas in the adrenal cortex by 6 months of age (5-7, 9, 12) . We gonadectomized weanling female DBA/2J (a susceptible strain) or FVB/N mice (a nonsusceptible strain) and then examined adrenal glands 0.5-8 months later. Consistent with published reports (5-9), small, densely arranged A cells began to accumulate beneath the adrenal capsule of DBA/2J mice within weeks of gonadectomy (Fig.  1A) . These subcapsular cells were polyhedral and had deeply staining nuclei with slightly basophilic cytoplasm. With time, the A cells extended between the epithelial cell columns of the zf and became spindle-shaped, resembling ovarian stroma (Fig. 1A) . As these cells increased in number they disrupted the arrangement of the zg and zf, resulting in the formation of wedge-shaped areas. A few months after gonadectomy, nests of large, lipid-laden B cells were evident in these areas (Fig. 1B) . Although small foci of A cells could be seen in the subcapsular region of older nongonadectomized DBA/2J mice, these cells did not invade deeply into the cortex, and no B cells were observed. Tumors are uncommon in the adrenal glands of intact FVB/N mice (41), and gonadectomy did not induce adrenocortical tumors in this strain ( Fig. 1, C and D) . Rare, small patches of A cells were observed in older FVB/N mice (Ͼ6 months of age), but these cells were not invasive, and no B cells were seen in these animals (data not shown).
To ensure that these strain differences in tumor development were not due to differences in gonadotropin levels, we measured serum LH levels in DBA/2J and FVB/N mice before and after ovariectomy (Table 1) . Baseline and gonadectomy-induced changes in LH levels were comparable in the two strains.
GATA-4 protein is expressed in neoplastic cells that accumulate in the adrenal cortex of gonadectomized female DBA/2J mice
Based on previous studies with inhibin-␣ promoter SV40 T antigen transgenic mice, which develop GATA4-expressing adrenocortical carcinomas after gonadectomy (24), we hypothesized that changes in GATA factor expression might accompany adrenal tumor formation in gonadectomized DBA/2J mice. To assess the impact of gonadectomy on adrenocortical expression of GATA-4 protein, we performed immunoperoxidase staining on intact female DBA/2J mice or littermates that had been subjected to gonadectomy 0.5-1 months earlier. In nongonadectomized DBA/2J mice, small foci of GATA-4-positive cells were seen in the subcapsular region ( Fig. 2 , A and C). These cells, which were histologically identical to A cells, did not invade deeply into the adrenal cortex. In contrast, large patches of GATA-4-positive A cells were evident in gonadectomized animals ( Next we used immunohistochemistry to compare the expressions of GATA-4 and GATA-6 in the adrenal glands of DBA/2J females that had been gonadectomized 4 months earlier. While no GATA-4 antigen was evident in normal adrenocortical cells, there was intense GATA-4 immunostaining in the nuclei of both A and B cells in the subcapsular tumors of gonadectomized DBA/2J mice (Fig. 4, A and B) . GATA-6 protein was detected in the nucleus of normal adrenocortical cells, but not in A cells of gonadectomized DBA/2J mice (Fig. 4C) . Faint expression of GATA-6 protein was evident in B cells of ovariectomized mice (Fig. 4C) . We conclude that GATA-4 is a marker of the neoplastic A and B cells that accumulate in the adrenal glands of female DBA/2J mice after gonadectomy, whereas GATA-6 expression is down-regulated in A cells. Weanling DBA/2J or FVB/N mice were subjected to sham surgery or gonadectomy (Gdx). At the indicated times, serum LH levels were measured as described in Materials and Methods. Values represent the mean Ϯ SEM of four to six measurements. 
Changes in GATA-4, LHR, and P450c17 mRNA levels in the adrenal cortex of DBA/2J mice after gonadectomy
To show correlation between GATA-4 expression and adrenocortical tumor development, we used RNase protection assays to measure GATA-4 mRNA in the adrenal glands of DBA/2J mice at various time points after gonadectomy (Fig.  5) . In light of earlier reports demonstrating that GATA-4 and LHR are coexpressed in another mouse model of adrenocortical tumorigenesis (24), we also performed RNase protection assays for LHR mRNA. In agreement with published studies on other mouse strains (23, 24, 34) , neither GATA-4 nor LHR mRNA was detected in the adrenal glands of intact, weanling, female DBA/2J mice (Fig. 5, left panel) . There was only weak expression of GATA-4 and LHR mRNA in the adrenals of older intact adult DBA/2J females (Fig. 5, left  panel) , and neither of these transcripts was evident in older gonadectomized FVB/N females (Fig. 5, right panel) . Compared with intact animals of the same age, gonadectomized female DBA/2J mice exhibited a marked increase (10-to 15-fold by phosphorimage analysis) in the steady state levels of GATA-4 and LHR mRNA within the adrenal gland (Fig.  5, left panel) . These increases in the levels of GATA-4 and LHR mRNA were evident as early as 0.5 months after ovariectomy and reached a maximum by 4 months. In castrated male DBA/2J mice, more modest increases in GATA-4 and LHR mRNA levels were noted and only after a longer latency period (Fig. 5, center panel) . This correlates with the observation that gonadectomized female DBA/2J mice develop adrenocortical tumors more readily than their male counterparts (9), which may be related to lower levels of serum LH that accompany gonadectomy in males vs. females (42) . In contrast to GATA-4 and LHR, the level of GATA-6 mRNA remained relatively constant after gonadectomy, with the exception of a transient decrease in the female adrenal 1 month after gonadectomy (Fig. 6, upper panel) .
P450c17, an enzyme required for the synthesis of sex steroids, is expressed in the fetal adrenal, but is normally absent from the adrenals of postnatal mice (43) . Hence, the developmental expression pattern of P450c17 in the adrenal cortex coincides with that of GATA-4 (23) . RNase protection assays demonstrated that adrenal expression of P450c17 mRNA increased dramatically after gonadectomy in female and male DBA/2J mice (Fig. 6, upper panel) , similar to the pattern observed for GATA-4 and LHR transcripts. As expected, gonadectomized FVB/N mice did not exhibit an increase in P450c17 expression (Fig. 6, lower panel) . We conclude that gonadectomy of female or male DBA/2J mice is accompanied by increased expression of GATA-4, LHR, and P450c17 within the adrenal gland, and that there is a tight temporal correlation between the expression of these transcripts and the appearance of neoplastic cells in the adrenal cortex. Moreover, strain susceptibility to adrenocortical tumorigenesis (DBA/2J Ͼ Ͼ FVB/N) correlates with expression of GATA-4, LHR, and P450c17 after gonadectomy.
Localization of transcripts for GATA-4, LHR, P450c17, and other steroidogenic markers in the adrenocortical tumors that develop in gonadectomized DBA/2J mice
In situ hybridization was used to localize the expression of GATA-4, LHR, and other key markers in the adrenal glands from intact and gonadectomized female DBA/2J mice (Fig.  7) . A cells and B cells expressed abundant GATA-4 (Fig. 7 , E and I) and LHR (Fig. 7, F and J) mRNA. In contrast, P450c17 showed a patchy expression that localized exclusively to B cells (Fig. 7, H and L) , the presumed source of sex steroids in the tumors of gonadectomized mice. Inhibin-␣ is ex- pressed in human adrenocortical tumors (44) and in a transgenic mouse model of adrenocortical tumorigenesis (25, 26) . Based on gene disruption studies in mice, inhibin-␣ is considered to be a tumor suppressor in gonads (45) , and gonadectomy of inhibin-␣Ϫdeficient mice results in the appearance of adrenocortical tumors (46) . In ovariectomized DBA/2J mice, inhibin-␣ mRNA was detected in B cells and, to a lesser extent, in A cells in adrenocortical tumors (Fig. 7 , G and K). Little inhibin-␣ mRNA was observed in normal adrenocortical cells (Fig. 7G) . The expression of other factors involved in steroidogenesis was altered profoundly in the adrenocortical tumors found in gonadectomized mice. mRNA for SF-1, a transcription factor that regulates a variety of genes in steroidogenic cells (47) , was reduced in areas rich in A cells (Fig. 7D) . Compared with normal cells of the zg or zf, A cells expressed little mRNA for either P450scc, an enzyme that converts cholesterol to pregnenolone (1) (Fig. 7B) , or StAR, a factor that mediates the delivery of cytosolic cholesterol to the mitochondrial inner membrane (48) (Fig.  7C) . B cells did express transcripts for SF-1, GATA-6, P450scc, and StAR in amounts comparable to normal adrenocortical epithelial cells (data not shown). Collectively, the expression patterns of these key steroidogenic markers confirm the long-standing idea that A cells have limited steroidogenic capacity (9, 11, 12) , whereas B cells have the capacity to produce sex steroids (9, 12, 13) . The overlapping patterns of expression of GATA-4 and LHR emphasize the relationship between these factors and gonadotropin-associated adrenocortical neoplasia.
Ovarian regeneration limits adrenocortical tumor development in ovariectomized DBA/2J mice
Unilateral regeneration of ovarian tissue occurs in some inbred mice (Ͻ15%) undergoing complete bilateral ovariectomy (28) . This regenerated tissue typically arises in the vicinity of the distal oviduct and has a distinctive appearance, characterized by a small number of follicles and luteinized ovarian stromal tissue (28) . Despite this unusual appearance, regenerated ovarian tissue is capable of sex steroid production, and estrous may resume within weeks of complete ovariectomy (28) . We observed regenerated ovarian tissue in a subset of female mice that had undergone gonadectomy and then resumed estrous (Fig. 8, A and B) . This regenerated tissue contained spindle-shaped stromal cells that expressed GATA-4 (Fig. 8C) . Two months after surgery, animals with regenerated ovarian tissue had serum LH levels (1.1 Ϯ 0.3 ng/ml; n ϭ 4) comparable to those in sham-operated DBA/2J mice (see Table 1 ), confirming that the regenerated ovarian tissue was functional and produced hormones capable of feedback inhibition of the pituitary gland.
Ovarian regeneration and the resumption of sex steroid production had a profound influence on adrenal tumor development (Fig. 8D vs. 8G) . The adrenal glands from mice with ovarian regeneration contained small collections of A cells (Fig. 8D, black arrow) , but lacked B cells. The mRNA expression patterns of the steroidogenic enzymes P450 11␤-hydroxylase (11␤-OHase) and P450 aldosterone synthase followed the distribution observed in normal adrenal glands (47) and differed from those of gonadectomized females in which ovaries were completely absent (Fig. 8, E and F vs. H and I). RNase protection assays at 2 months postgonadectomy showed that GATA-4 mRNA expression was reduced in the adrenals of animals with regenerated ovarian tissue compared with animals without ovarian regeneration (Fig.  9) . Furthermore, the adrenal glands from animals with regenerated ovarian tissue did not express LHR or P450c17 (Fig. 9) . Thus, in the presence of ovarian regeneration, limited A cell proliferation occurs, but B cell differentiation is halted.
Discussion
Woolley and collaborators (5) first demonstrated that gonadectomy caused undifferentiated cells in the subcapsular region of the female mouse adrenal cortex to be transformed into sex steroid-producing cells that are histologically and functionally similar to ovarian tissue. Subsequent studies established that gonadectomy-induced adrenocortical tumor formation occurs in both female and male mice, but is highly strain dependent (6 -9) . The most susceptible strain, CE, develops adrenocortical carcinomas (7) . DBA/2J, C3H, and BALB/c mice develop adrenocortical adenomas (6 -10), FIG. 5 . GATA-4 and LHR mRNA levels in the adrenal glands of intact vs. gonadectomized DBA/2J and FVB/N mice. Weanling mice were subjected to gonadectomy (GDX) or sham surgery, and adrenal glands were harvested 0.5-6 months later. RNase protection assays for GATA-4 and LHR were performed as described in Materials and Methods. ␤-Actin mRNA levels were measured simultaneously to control for RNA recovery and loading. The left, center, and right panels show female DBA/2J, male DBA/2J, and female FVB/N mice, respectively. The GATA-4 riboprobe protects a fragment of 430 nucleotides, whereas the ␤-actin probe protects a fragment of 250 nucleotides. The LHR riboprobe protects a series of small fragments due to complex alternative splicing of this transcript (35, 36) . This experiment was repeated on three separate occasions with identical results. In separate experiments (not shown), we confirmed that neither GATA-4 nor LHR mRNA was detectable in gonadectomized or sham-operated FVB/N mice at earlier time points (0.5 or 1 month).
whereas other stains, including C57BL/6J (10) and FVB/N (this study), are resistant to tumor formation.
The phenomenon of gonadotropin-induced adrenocortical tumorigenesis is not unique to mice. Subcapsular, spindle cell tumors have been reported in the adrenal glands of other gonadectomized rodents, such as rats, guinea pigs, hamsters, and ferrets (10, 49) . Often these tumors produce ectopic sex steroids. Moreover, spindle cell neoplasms have been described in the subcapsular region of the adrenal cortex in humans with high serum gonadotropin levels, including postmenopausal women (50 -54) and men with acquired testicular atrophy (55) . In women, these adrenocortical changes have been termed thecal metaplasia because of the histological similarities with theca-interstitial cells of the ovary. In some instances these subcapsular human adrenocortical tumors have been associated with increased sex steroid production (52, 56, 57) . The overall incidence of gonadotropininduced adrenal neoplasms in humans is difficult to quantify, although autopsy series suggest that incidental adrenocortical tumors are present in approximately 5% of older women and men (58) .
That a variety of species exhibit the phenomenon of gonadotropin-induced adrenocortical neoplasia suggests that mammalian adrenal glands contain progenitor cells that can proliferate and differentiate into sex steroid-producing stroma in response to continuous gonadotropin signaling. The origin of these neoplastic adrenocortical cells, which share properties with somatic/interstitial cells of the gonads, remains elusive. Whether a common stem cell gives rise to epithelial cells in the zg or zf and also to these stromal progenitors is unknown. Rare isolated cells with morphological features of Leydig cells have been reported in human adrenal cortex (59 -61) . In rodents there is evidence that steroidogenic cells of the gonads and adrenals originate from a common set of progenitors near the anterior end of the mesonephros (62) . Alternatively, these cells may be derived from pluripotent cells that arise from coelomic epithelium (63) .
Studies of the origin of adrenocortical stromal cells have been hampered in part by a paucity of suitable markers. We have found that gonadectomy of DBA/2J mice results in a marked increase in GATA-4 mRNA and protein in a sensitive population of subcapsular adrenocortical cells corresponding to the previously described A cells (5-7). These cells, which also express LHR, are not steroidogenic since they lack expression of markers such as SF-1, StAR, p450scc, P450 11␤-OHase, or P450 aldosterone synthase. Instead they proliferate and differentiate presumably giving rise to B cells within developing tumors (5-9). B cells express a range of steroidogenic markers including p450c17, an enzyme capable of synthesizing sex steroids. Ectopic sex steroids produced by B cells elicit physiological effects, such as estrogen-induced changes in the endometrial lining or androgen-induced changes in the epithelial lining of Bowman's capsule (5-9). The presence of GATA-4 and LHR in both A and B cells supports histological evidence (5-9) that nonsteroidogenic A cells transform into sex steroid-producing B cells.
Previous studies have shown that GATA-4 is expressed in a variety of steroidogenic cells in the normal mouse, including Sertoli, Leydig, granulosa, thecal, and fetal adrenal cells (16 -20, 23, 24) . GATA-4 is also expressed in interstitial cells of the ovary and testes. In gonadal cells, GATA-4 has been implicated in the regulation of both tissue-specific gene expression (64, 65) and cellular proliferation (16 -18, 66, 67) . These findings coupled with our observation that cells expressing GATA-4 accumulate in the adrenal glands of gonadectomized DBA/2J mice suggest that GATA-4 plays a role in both differentiation and gonadotropin-induced proliferation of certain cell populations in the gonads and adrenals.
The expression of GATA-4 and LHR has been observed in another mouse model of adrenocortical tumorigenesis, namely that of inhibin-␣ promoter-SV40 T antigen transgenic mice, which develop adrenocortical carcinomas after gonadectomy (25, 26) . Thus, enhanced GATA-4 expression and LH signaling have been linked to adrenocortical tumorigenesis in two independent mouse models, including one that is not reliant on the potent oncogene large T antigen. Although there are similarities in adrenocortical tumorigenesis in the inhibin-␣ promoter-SV40 T antigen transgenic and DBA/2J mouse models, there are some differences. For example, tumors in the transgenic mouse model develop later in life and are carcinomas rather than adenomas (24 -26) . The inter-FIG. 6. P450c17 and GATA-6 mRNA levels in the adrenal glands of intact vs. gonadectomized DBA/2J and FVB/N mice. Weanling mice were subjected to gonadectomy (GDX) or sham surgery, and adrenal glands were harvested 1-6 months later. RNase protection assays for P450c17 and GATA-6 were performed as described in Materials and Methods. ␤-Actin mRNA levels were measured simultaneously to control for RNA recovery and loading. The upper and lower panels show DBA/2J and FVB/N mice, respectively. The P450c17 riboprobe protects a fragment of 324 nucleotides, the ␤-actin probe protects a fragment of 250 nucleotides, and the GATA-6 riboprobe protects a fragment of 140 nucleotides. This experiment was repeated twice with identical results.
relationship between GATA-4 and LHR in gonadectomyassociated adrenocortical tumors has not been fully elucidated and is the subject of ongoing investigation.
In contrast to GATA-4, there is little GATA-6 expression in the A cells that accumulate in the adrenal glands of gonadectomized DBA/2J mice or in the adenocarcinoma cells that form in gonadectomized inhibin-␣ promoter-SV40 T antigen transgenic mice (24) . GATA-6 expression decreases when certain other cell types, including vascular smooth muscle cells and glomerular mesangial cells, are induced to proliferate (68) . Transient transfection with GATA-6 induces growth inhibition in smooth muscle cells, fibroblasts, and glomerular mesangial cells, and that inhibition is dependent on the presence of the cyclin-dependent kinase inhibitor p21 cip1 (69, 70) . Hence, down-regulation of GATA-6 expression may be critical for the cellular proliferation that accompanies A cell accumulation in gonadectomized DBA/2J adrenals. On the other hand, GATA-6 expression is evident in B cells found in the adrenal glands of gonadectomized DBA/2J mice, suggesting that this transcription factor is involved in steroidogenesis in these cells.
Adrenocortical tumors often show dysregulation of P450c17 expression (71-73). We found that adrenal tumor formation in gonadectomized DBA/2J mice is accompanied by increased expression of P450c17 from early stages onward. During fetal mouse development there is a transient expression of P450c17 in a subset of adrenocortical cells between embryonic d 12.5 (E12.5) and E14.5 (43) . P450c17 expression ceases between 16.5 and term (E18.5) and is absent from the adrenal glands of adult mice (43) . Consequently, adrenal glands from adult mice produce corticosterone and aldosterone, but not cortisol or sex steroids. The spatial and temporal expression patterns of different steroid hydroxylases in the adrenal suggest that multiple factors are required to program cell type and species-specific expression. GATA-4 is expressed at the same time as P450c17 in fetal mouse adrenal (23) , and LHR appears transiently in human fetal adrenal at the same time as GATA-4 (23) . As the P450c17 promoter contains multiple GATA elements, and its in vitro expression is enhanced by cAMP (74) , it is tempting to speculate that the presence of GATA-4 and the activation of LHR are necessary or sufficient to promote P450c17 steroidogenic activity in the adrenal tumors of gonadectomized DBA mice.
As discussed earlier, only certain inbred mouse strains, DBA/2J included, respond to gonadectomy by developing adrenocortical tumors. It has been shown recently that DBA/2J mice carry a polymorphism in the gene encoding SF-1, which results in an Ala3 Ser substitution at residue 172 of the protein (75) . This polymorphism appears to influence steroidogenesis; the SF1 A172 allele is present in mouse strains with high steroidogenic capacity (e.g. Weanling female mice were subjected to gonadectomy, and then adrenal glands were harvested 2 months later. Mice with and without ovarian regeneration were identified by careful inspection. RNase protection assays for GATA-4 (lanes 1, 2), LHR (lanes 3, 4), P450c17 (lanes 5, 6), and GATA-6 (lanes 5, 6) were performed as described in Materials and Methods. ␤-actin mRNA levels were measured simultaneously to control for RNA recovery and loading. This experiment was repeated twice with identical results. C57BL/6J), whereas the SF1 S172 allele is found in strains with low steroidogenic capacity (e.g. DBA/2J and C3H/ HeJ) (75) . Mutant Y1 adrenocortical tumor cell lines expressing the SF1 S172 allele are ACTH resistant, although the SF1 S172 allele appears to not be directly responsible for this effect (75, 76) . Isolated Leydig cells from strains that contain the SF1 A172 (C57BL/6J) produce twice as much testosterone in response to hCG stimulation as cells from strains carrying the SF1 S172 allele (DBA/2J) (77) . It is intriguing that strains with the SF1 S172 allele are those that develop postgonadectomy adrenocortical tumors, whereas a strain with the SF1 A172 allele (C57BL/6J) is resistant to tumor formation. The SF1 polymorphism and its hormonal consequences may render gonadectomized DBA/2J mice prone to adrenal tumor development.
There is a delay in the onset of tumorigenesis and in the expression of GATA-4 and LHR after gonadectomy in male vs. female DBA/2J mice. Postgonadectomy levels of gonadotropins and other circulating hormones differ between genders (42), which may account for these differences in the rate of tumor progression. Once started, the process of neoplasia appears to follow similar paths in males and females, judging from the expression of GATA-4, LHR, and p450c17 in the adrenal tumors of both sexes.
Previous studies have shown that various signaling pathways are disrupted in adrenocortical tumors (78 -80) . Ectopic expression of LHR has been reported in adrenocortical neoplasms of mice (24 -26) and humans (79) , and a concomitant increase in GATA-4 expression has been noted in some of these cases (Ref. 24 and this study). We postulate that ectopic expression of LHR in adrenocortical cells confers inappropriate sensitivity to LH, which, in conjunction with GATA-4, leads to changes in cell proliferation, differentiation, or steroid production. Future studies will focus on how GATA-4 and LHR interact with one another and with other signaling molecules, such as activin receptors and Smad2 (80) , during the process of adrenocortical tumorigenesis.
